UnknownPhase 3

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer

NCT03926091

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Chongqing Cancer Hospital

Chongqing, Chongqing Municipality, China

+13 additional locations

Contact

Zhimin Shao, MD, PhD

Save this trial

Chongqing Cancer HospitalChongqing, Chongqing Municipality, China
Fujian Medical University Union HospitalFuzhou, Fujian, China
Sun Yet-Sen Memorial Hospital, Sun Yet-Sen UniversityGuangzhou, Guangdong, China
Harbin Medical University Cancer HospitalHarbin, Heilongjiang, China
The First Bethune Hospital of Jilin University (The First Hospital of Jilin University)Changchun, Jilin, China
The Second Hospital of Dalian Medical UniversityDalian, Liaoning, China
The First Hospital of China Medical UniversityShenyang, Liaoning, China
The Affiliated Hospital of Qingdao UniversityQingdao, Shandong, China
OB/GYN Hospital of Fudan UniversityShanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer HospitalShanghai, Shanghai Municipality, China
Tianjin Medical University Cancer Institute and HospitalTianjin, Tianjin Municipality, China
The First Affiliated Hospital, ZheJiang UniversityHangzhou, Zhejiang, China
Zhejiang Cancer HospitalHangzhou, Zhejiang, China
The Second Affiliated Hospital of Zhejiang University School of MedicineHanzhou, Zhejiang, China